International Consensus Guidelines for Management of Intraductal Papillary Mucinous Neoplasms and Mucinous Cystic Neoplasms of the Pancreas

By Masao Tanaka, S. Chari, V. Adsay, C. Fernández‐del Castillo, M. Falconi, M. Shimizu, K. Yamaguchi, K. Yamao, S. Matsuno. Pancreatology (Print), 2006

2,010 citations recorded by the source corpus.

Subfields: Oncology, Surgery

View Paper: https://www.semanticscholar.org/paper/e486d4b1d84f8ae5b252bc8241adbc5c66905bbb

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. Masao Tanaka
2. T. Kamisawa
3. C. F. Fernandez-Del Castillo
4. J. Jang
5. Philippe Lévy
6. L. Berland
7. Takao Ohtsuka
8. R. Salvia

Citations in the corpus

• Managing incidental findings on abdominal CT: white paper of the ACR incidental findings committee. (2010, background): “If they grow above 3 cm or develop any orrisome features, patients are considered candidates for esection [88].”
• Revisions of international consensus Fukuoka guidelines for the management of IPMN of the pancreas. (2017, background): “resection of most pancreatic cysts, and although in very few centers this continues to be the case, following the publication of the International Association of Pancreatology (IAP) Sendai guidelines in 2006 [1] and the subsequent Fukuoka guidelines in 2012 [2], a more conservative attitude is follo”
• International Cancer of the Pancreas Screening (CAPS) Consortium summit on the management of patients with increased risk for familial pancreatic cancer (2012, positive): “Pathologically con fi rmed PanIN-3 lesions have been found in the pancreata of individuals who had resections of IPMNs smaller than 1 cm. 5 11 High-grade dysplasia and main-duct involvement have been identi fi ed at resection of some individuals who had surgery for one or more small ( 3 cm) BD-IPMNs.”